Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
133 hedge funds and large institutions have $521M invested in Silk Road Medical, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 49 increasing their positions, 44 reducing their positions, and 58 closing their positions.
12% more call options, than puts
Call options by funds: $3.71M | Put options by funds: $3.32M
11% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 44
13% less capital invested
Capital invested by funds: $597M → $521M (-$76.4M)
20% less funds holding
Funds holding: 166 → 133 (-33)
57% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$27M |
| 2 |
JFG
Jefferies Financial Group
New York
|
+$17.9M |
| 3 |
AC
Armistice Capital
New York
|
+$16.6M |
| 4 |
Goldman Sachs
New York
|
+$16.5M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$13.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
-$25.9M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$15.6M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$14.4M |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$10.7M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$9.08M |
SILK Hedge Fund Activity: Q4 2023 in Review
133 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q4 2023, worth a combined $521M — down 13% from $597M a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of SILK and 25 opened new positions — a net loss of 33 holders — while 44 trimmed existing stakes and 49 added.
The largest buyer was Morgan Stanley, adding an estimated $27M. The largest seller was ClearBridge Investments, exiting entirely with an estimated $25.9M sold.
- 133 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q4 2023, down from 166 in Q3 2023.
- Funds reported $521M of Silk Road Medical, Inc. Common Stock stock for Q4 2023, down 13% quarter-over-quarter.
- 25 funds opened new Silk Road Medical, Inc. Common Stock positions in Q4 2023 and 58 closed out, a net change of -33 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $27M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q4 2023 was ClearBridge Investments, an estimated $25.9M sold.
Based on aggregated 13F filings for Q4 2023.